Anatomic Stage IV Breast Cancer AJCC v8 Clinical Trials in Bloomington, Illinois

3 studies are recruiting for anatomic stage iv breast cancer ajcc v8 in Bloomington, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

    This phase III trial evaluates the effect of adding locoregional therapy (surgery and radiation) and metastasis-directed stereotactic body radiation therapy (SBRT) to standard systemic therapy following standard HER2-targeted systemic therapy, compared to standard systemic therapy alone, in treatin…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    OSF Saint Joseph Medical Center, Bloomington, Illinois
    Locations
    59 in total
    Run by
    SWOG Cancer Research Network

    See if you can join NCT07578116 on ClinicalTrials.gov

  2. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) …

    Stage
    Phase 2
    Ages
    Any age
    Site
    Illinois CancerCare-Bloomington, Bloomington, Illinois
    Locations
    483 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT05564377 on ClinicalTrials.gov

  3. S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

    This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body. Using markers to prompt when scans should be ordered may be as good as …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Illinois CancerCare-Bloomington, Bloomington, Illinois
    Locations
    723 in total
    Run by
    SWOG Cancer Research Network

    See if you can join NCT03723928 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.